USRD - ETF AI Analysis
Top Page
(undefined)
Rating:73Outperform
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered solid gains so far this year, suggesting its strategy has recently worked well for investors.
Leading Growth Companies in Top Holdings
Many of the largest positions, especially in technology and health care, have shown strong performance, helping drive the fund’s returns.
Focused Yet Multi-Sector Exposure
While the fund emphasizes technology and health care, it still holds companies across several sectors, offering some diversification within its R&D theme.
Negative Factors
Heavy Tilt Toward Technology
With a large share of assets in technology stocks, the fund could be more sensitive to downturns in that sector.
U.S.-Only Geographic Exposure
Almost all holdings are in U.S. companies, so investors get little diversification across different global markets.
Mixed Performance Among Top Holdings
A few key positions have recently shown weaker or negative performance, which could weigh on the ETF if those stocks continue to lag.
USRD vs. SPDR S&P 500 ETF (SPY)
AUMN/A
RegionN/A
Expense RatioN/A
BetaN/A
IssuerN/A
Inception DateN/A
Dividend YieldN/A
Asset ClassN/A
Index TrackedN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume162
30 Day Avg. Volume209
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst CoveringN/A
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
USRD Summary
Themes US R&D Champions ETF (USRD) follows the Solactive US R&D Champions Index, focusing on U.S. companies that spend heavily on research and development. It holds a wide mix of large, medium, and small firms, with a big tilt toward technology and health care. Well-known holdings include Advanced Micro Devices (AMD) and Eli Lilly. Someone might invest in USRD to get broad exposure to the U.S. stock market while targeting innovative, growth-oriented businesses. A key risk is that it is heavily tilted toward tech and other R&D-driven stocks, so its price can rise and fall sharply with market and innovation cycles.
How much will it cost me?The Themes US R&D Champions ETF (USRD) has an expense ratio of 0.29%, meaning you’ll pay $2.90 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to focus on innovative companies with high R&D spending. The extra cost reflects the specialized strategy and research involved in selecting these forward-thinking investments.
What would affect this ETF?The USRD ETF, with its strong focus on technology and R&D-driven companies, could benefit from advancements in innovation and increased demand for cutting-edge solutions, especially in sectors like technology and healthcare. However, it may face challenges from rising interest rates, which can impact growth-focused companies, and potential regulatory changes affecting tech giants like Alphabet and Apple. Economic conditions in the U.S., such as a slowdown in consumer spending, could also influence the ETF's performance.
USRD Top 10 Holdings
USRD is leaning heavily into U.S. tech innovators, with cybersecurity names like Palo Alto Networks and Fortinet and cloud player Datadog doing much of the heavy lifting as their shares keep rising. Chip makers AMD and Lam Research add more fuel, riding the AI and semiconductor boom, though Applied Materials and ARM have seen more mixed, recently lagging action as valuation worries creep in. Eli Lilly offers a health care counterweight with steadier, if less explosive, momentum. Overall, this is a U.S.-centric, R&D-driven tech story with a few non-tech anchors for balance.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Datadog | 3.56% | $39.54K | $89.30B | 66.95% | 69 Neutral | |
| Fortinet | 3.39% | $37.64K | $109.88B | 50.64% | 71 Outperform | |
| Palo Alto Networks | 3.31% | $36.81K | $259.99B | 71.64% | 73 Outperform | |
| Advanced Micro Devices | 2.63% | $29.20K | $741.30B | 139.30% | 73 Outperform | |
| Applied Materials | 2.46% | $27.40K | $378.29B | 130.45% | 77 Outperform | |
| Axon Enterprise | 2.46% | $27.32K | $44.14B | -29.04% | 58 Neutral | |
| ARM Holdings PLC ADR | 2.37% | $26.37K | $260.40B | 37.69% | 69 Neutral | |
| Eli Lilly & Co | 2.37% | $26.35K | $1.15T | 59.20% | 72 Outperform | |
| Cisco Systems | 2.34% | $26.01K | $455.55B | 64.74% | 77 Outperform | |
| Apple | 2.33% | $25.94K | $4.99T | 61.77% | 79 Outperform |
USRD Technical Analysis
Positive
―
Price Trends
37.75
Negative
35.55
Positive
34.51
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For USRD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.75, equal to the 50-day MA of 37.75, and equal to the 200-day MA of 34.51, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for USRD.
USRD Peer Comparison
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents